Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
The Budgetary Impact of Diabetic Comorbidities | Physician & Payer Forum | Brazil and Mexico | 2015
A Focus on Prescribing Trends and Payer Strategy for Diabetic Macular Edema and Diabetic Nephropathy Patients with type 2 diabetes (T2D) often present with multiple comorbidities, which boosts…
The Impact of Payer Policy on Uptake of GLP-1 Receptor Agonists and Insulins for Type 2 Diabetes | Physician & Payer Forum | US | 2015
A Survey of Primary Care Physicians, Endocrinologists, and Managed Care Organization Pharmacy and Medical Directors Type 2 diabetes is a complex metabolic disorder characterized by a declining…
Biosimilars Advisory Service : US and EU Payer Perspectives on Biosimilars | US/EU | 2015
How payers choose to adopt and promote biosimilars will be highly impactful in determining the future commercial opportunity for biosimilars in the United States and across Europe. We conducted…
What Are the U.S. Market Access Levers and Hurdles Facing Orally Administered, Small-Molecule Targeted Oncology Drugs for Renal Cell Carcinoma and Hepatocellular Carcinoma? | Physician & Payer Forum | US| 2015
A Survey of Medical Oncologists and Managed Care Organization Pharmacy and Medical Directors The hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC) markets differ with respect to…